The landscape of dementia prognosis has evolved radically with the advent of innovative biomarkers, together with amyloid PET scans, tau imaging, and blood-based exams that could detect Alzheimer's pathology yrs before signs and symptoms emerge. Even though these technological advancements stand for remarkable progress in knowledge neurodegenerativ